Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease-Reference-Cited by-同舟云学术

Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease

Published:2017-03-31 Issue:20 Volume:38 Page:1597-1607
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Zewinger Stephen,Kleber Marcus E.,Rohrer Lucia,Lehmann Marlene,Triem Sarah,Jennings Richard T.,Petrakis Ioannis,Dressel Alexander,Lepper Philipp M.,Scharnagl Hubert,Ritsch Andreas,Thorand Barbara,Heier Margit,Meisinger Christa,de las Heras Gala Tonia,Koenig Wolfgang,Wagenpfeil Stefan,Schwedhelm Edzard,Böger Rainer H.,Laufs Ulrich,von Eckardstein Arnold,Landmesser Ulf,Lüscher Thomas F.,Fliser Danilo,März Winfried,Meinitzer Andreas,Speer Thimoteus

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/38/20/1597/17240383/ehx118.pdf

Reference40 articles.

1. . European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts);European Society of Cardiology Committee for Practice Group;Eur Heart J,2007

2. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis;Chronic Kidney Disease Prognosis C;Lancet,2012

3. Chronic kidney disease: effects on the cardiovascular system;Circulation,2007

4. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis;Chronic Kidney Disease Prognosis Consortium;Lancet,2012

5. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR);Authors/Task Force Members;Eur Heart J,2016

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased high-density lipoprotein cholesterol in patients with type 2 diabetes and its correlates: a cross-sectional, matched case–control survey;European Journal of Medical Research;2024-07-02

2. Labordiagnostik von Fettstoffwechselstörungen;Diabetes aktuell;2024-05

3. Post-translational modifications in kidney diseases and associated cardiovascular risk;Nature Reviews Nephrology;2024-04-25

4. Meta-analysis of the correlation between pulmonary hypertension and echocardiographic parameters in patients with chronic kidney disease;PeerJ;2024-04-19

5. Lipoprotein dysfunction in patients with chronic kidney disease (CKD). Pathogenesis and treatment of CKD dyslipidemia (literature review);Nephrology (Saint-Petersburg);2024-03-03